Key result
In situ hardware sterilization shows potential as a salvage strategy for focally infected ICDs.
Case Report
In situ hardware sterilization is presented as a potential strategy for salvaging focally infected implantable cardioverter-defibrillator systems.
Answers are grounded in this paper and cite their sources.
May support in situ sterilization as salvage for focal ICD infections; leaves open safety and efficacy pending prospective data.
Cardiovascular implantable electronic device (CIED)-related infections have increased in frequency over the past 2 decades out of proportion to the rise in device implantations.1 This has occurred despite an improvement in technology, which includes smaller device profiles, improvement in battery life, prepectoral systems, and greater operator experience. Much of what is driving this trend is the greater implantation rate of implantable cardiac defibrillators (ICD), which are more likely to become infected than permanent pacemakers, possibly owing to greater surface area for bacterial adherence.
No takes yet. Share an insight, caveat, or question.
Schaller et al. (2017) conducted a case report in Cardiovascular implantable electronic device (CIED)-related infections. In situ hardware sterilization was evaluated. In situ hardware sterilization was discussed as a potential salvage strategy for focally infected implantable cardioverter-defibrillator systems.
Synapse has enriched 10 related papers. Consider them for comparative context: